A promising new drug could help people living with post-traumatic stress disorder (PTSD) finally let go of trauma. This is the discovery of scientists at the Institute of Basic Science (IBS) and Ewha Womans University in South Korea who have identified a …

The challenge is to make the molecule really good at absorption and also, ensure that after decay, it will not produce toxic substances harmful to the body, said Orentas. When Group Captain Shubhanshu Shukla, the second Indian citizen in space, reached the …

Back pain can really interfere with your quality of life, and it's one of the most common reasons people miss work. If you've never had back pain before, just wait. About one in four people in the U.S. are currently dealing with lower back pain, …

Alzheimer's disease is largely seen as one of old age. The most common form of memory-robbing dementia, Alzheimer's affects nearly 7 million Americans, most of whom are over the age of 65. In general, about one in 14 people develop the disease by …

Details behind a new phase 2 proof-of-concept study, dubbed PRIMUS-AD (NCT06182085), testing investigational PRI-002 (PRInnovation), an oral small-molecule anti-amyloid-ß (Aß) oligomer disaggregator, were unveiled at the 2025 Alzheimer’s Association …

A groundbreaking new drug has been shown to slow the progress of Alzheimer's disease, with users also seeing improvement in their cognitive function, according to reports. The treatment, which was licensed for use in the UK last year, has been shown in …

Cancer drug combo shows promise against Alzheimer’s, an animal study shows. Image credit: Thana Prasongsin/Getty Images This article originally appeared on Medical News Today Researchers are actively seeking treatments or a cure for Alzheimer’s disease …

Taipei, July 31 (CNA) Kisunla, a newly approved Alzheimer's drug in Taiwan, will not be covered by the National Health Insurance (NHI) system, while coverage for Leqembi, another Alzheimer's treatment approved this year, is still under review, a …

Imagine shedding weight while sitting quietly watching TV, even without cutting calories. A pioneering pill called SANA, created by Uruguayan startup Eolo Pharma, could one day make that possible. Early human data in a statement by Eolo Pharma shows it can …

Picture a Montana that's the nation's hub for the $20 billion-and-growing longevity industry, a place where people from all over the world come to receive vanguard therapies that slow aging, allow them to live better for longer or finally ease …